RadNet, Inc. (RDNT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Core Insights - The company recently hosted its first Investor Day and announced a significant acquisition to enhance its artificial intelligence offerings, indicating a strong strategic direction for future growth [1] - The company reported a remarkable performance in the previous year, with revenue increasing by over 14.8% and substantial EBITDA growth, marking one of the best quarters in its history [1] - There has been consistent margin improvement over the last several quarters compared to the previous year's performance [1] Performance Metrics - Aggregate volumes have been strong, with same-center performance showing excellent results [2] - MRI volume has reached historic highs, with double-digit growth in same-center performance over the last two quarters [2] - CT volume has been growing in the mid-single digits, while PET/CT has shown exceptional growth of over 14% in the last two quarters compared to the prior year [2]